2023
DOI: 10.1093/ibd/izad003
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair

Abstract: Background Incidences of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, are escalating worldwide and can be considered a global public health problem. Given that the gold standard approach to IBD therapeutics focuses on reducing the severity of symptoms, there is an urgent unmet need to develop alternative therapies that halt not only inflammatory processes but also promote mucosal repair. Previous studies have identified increased stem cell factor (SCF) e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 62 publications
0
1
0
Order By: Relevance
“…Recent investigations have indicated the expression of SCF in dermal and intestinal epithelial cells ( 35 37 ). Reports have indicated elevated SCF expression in the inflamed mucosa of individuals with IBD, including SCF248 (a 248 amino acid cleavable form) ( 38 , 39 ).…”
Section: Discussionmentioning
confidence: 99%
“…Recent investigations have indicated the expression of SCF in dermal and intestinal epithelial cells ( 35 37 ). Reports have indicated elevated SCF expression in the inflamed mucosa of individuals with IBD, including SCF248 (a 248 amino acid cleavable form) ( 38 , 39 ).…”
Section: Discussionmentioning
confidence: 99%